These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18306931)

  • 1. The effect of combined treatment on head and neck human cancer cell lines with novel analogs of calcitriol and cytostatics.
    Wietrzyk J; Milczarek M; Kutner A
    Oncol Res; 2007; 16(11):517-25. PubMed ID: 18306931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in-vitro antiproliferative effect of PRI-2191 and imatinib applied in combined treatment with cisplatin, idarubicin, or docetaxel on human leukemia cells.
    Switalska M; Nasulewicz-Goldeman A; Opolska A; Maciejewska M; Kutner A; Wietrzyk J
    Anticancer Drugs; 2012 Jan; 23(1):70-80. PubMed ID: 21934605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
    Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
    Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model.
    Wietrzyk J; Nevozhay D; Milczarek M; Filip B; Kutner A
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):787-97. PubMed ID: 18188568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.
    Milczarek M; Filip-Psurska B; Swiętnicki W; Kutner A; Wietrzyk J
    Oncol Rep; 2014 Aug; 32(2):491-504. PubMed ID: 24919507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative activity of vitamin D compounds in combination with cytostatics.
    Pelczynska M; Switalska M; Maciejewska M; Jaroszewicz I; Kutner A; Opolski A
    Anticancer Res; 2006; 26(4A):2701-5. PubMed ID: 16886680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between VDR expression and antiproliferative activity of vitamin D3 compounds in combination with cytostatics.
    Pelczynska M; Wietrzyk J; Jaroszewicz I; Nevozhay D; Switalska M; Kutner A; Zabel M; Opolski A
    Anticancer Res; 2005; 25(3B):2235-40. PubMed ID: 16158969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simvastatin suppresses head and neck squamous cell carcinoma ex vivo and enhances the cytostatic effects of chemotherapeutics.
    Stoehr M; Mozet C; Boehm A; Aigner A; Dietz A; Wichmann G
    Cancer Chemother Pharmacol; 2014 Apr; 73(4):827-37. PubMed ID: 24562588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.
    Kotlarz A; Przybyszewska M; Swoboda P; Miłoszewska J; Grygorowicz MA; Kutner A; Markowicz S
    Tumour Biol; 2016 Apr; 37(4):4699-709. PubMed ID: 26511971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Side-chain-modified analogs of calcitriol cause resistance of human HL-60 promyelocytic leukemia cells to drug-induced apoptosis.
    Chrobak A; Radzikowski C; Opolski A
    Steroids; 2005 Jan; 70(1):19-27. PubMed ID: 15610893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcitriol and its analogues enhance the antiproliferative activity of gefitinib in breast cancer cells.
    Segovia-Mendoza M; Díaz L; González-González ME; Martínez-Reza I; García-Quiroz J; Prado-Garcia H; Ibarra-Sánchez MJ; Esparza-López J; Larrea F; García-Becerra R
    J Steroid Biochem Mol Biol; 2015 Apr; 148():122-31. PubMed ID: 25510900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effects of two less-calcemic vitamin D analogs (Paricalcitol and QW-1624F2-2) in squamous cell carcinoma cells.
    Alagbala AA; Johnson CS; Trump DL; Posner GH; Foster BA
    Oncology; 2006; 70(6):483-92. PubMed ID: 17237623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.
    Tsao AS; Liu S; Fujimoto J; Wistuba II; Lee JJ; Marom EM; Charnsangavej C; Fossella FV; Tran HT; Blumenschein GR; Papadimitrakopoulou V; Kies MS; Hong WK; Stewart DJ
    J Thorac Oncol; 2011 Dec; 6(12):2104-11. PubMed ID: 21892101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effects of imatinib (STI 571) in combination with chemotherapeutic drugs in head and neck cancer.
    Bruce IA; Slevin NJ; Homer JJ; McGown AT; Ward TH
    Anticancer Drugs; 2005 Aug; 16(7):719-26. PubMed ID: 16027519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antiproliferative activity of side-chain unsaturated and homologated analogs of 1,25-dihydroxyvitamin D(2). (24E)-(1S)-24-Dehydro-24a-homo-1,25-dihydroxyergocalciferol and congeners.
    Chodyński M; Wietrzyk J; Marcinkowska E; Opolski A; Szelejewski W; Kutner A
    Steroids; 2002 Aug; 67(9):789-98. PubMed ID: 12123791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of p21 promoter activity isolated from squamous carcinoma cell lines of the head and neck under the influence of 1,25(OH)2 vitamin D3 and its analogs.
    Hager G; Kornfehl J; Knerer B; Weigel G; Formanek M
    Acta Otolaryngol; 2004 Jan; 124(1):90-6. PubMed ID: 14977084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in anaplastic thyroid carcinoma cells.
    Kim E; Matsuse M; Saenko V; Suzuki K; Ohtsuru A; Mitsutake N; Yamashita S
    Thyroid; 2012 Jul; 22(7):717-24. PubMed ID: 22650230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
    Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent and sequence-dependent cytotoxicity of erlotinib and docetaxel in head and neck squamous cell carcinoma.
    Saigal B; Glisson BS; Johnson FM
    Anticancer Drugs; 2008 Jun; 19(5):465-75. PubMed ID: 18418213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.